Author:
Hardenberg M.C.,Patel B.,Matthews C.,Califano R.,Garcia Campelo R.,Grohe C.,Hong M.H.,Liu G.,Lu S.,de Marinis F.,Pérol M.,Soo R.A.,Stiles B.M.,Tiseo M.,Tsuboi M.
Reference32 articles.
1. Immunotherapy in non-metastatic non-small cell lung cancer: can the benefits of stage IV therapy be translated into earlier stages?;Deslypere;Ther Adv Med Oncol,2018
2. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Postmus;Ann Oncol,2017
3. Lung cancer (non-small-cell, first line)-gefitinib: appraisal consultation document | Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer | Guidance | NICE,2009
4. Adjuvant therapy for resected non-small cell lung cancer;Wozniak;Ther Adv Med Oncol,2009
5. Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art;Cortés;Transl Lung Cancer Res,2015
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献